Hongzhou Lu
Impact in
- Infectious Diseases top 0.5%
- COVID-19 Clinical Research Studies
- SARS-CoV-2 and COVID-19 Research
- HIV/AIDS Research and Interventions
- HIV/AIDS drug development and treatment
- SARS-CoV-2 detection and testing
- Virology top 1%
- HIV Research and Treatment
Papers in
- Virology 48
- HIV Research and Treatment 43
-
- HIV/AIDS Research and Interventions 51
- HIV/AIDS drug development and treatment 35
- COVID-19 Clinical Research Studies 29
- SARS-CoV-2 and COVID-19 Research 26
- Tuberculosis Research and Epidemiology 24
Hongzhou Lu
215 papers receiving 4.5k citations
Hit Papers
Peers
Comparison fields: 5 of 180
- Infectious Diseases 2.6k
- Virology 508
- Modeling and Simulation 220
- Neurology 606
- Biological Psychiatry 66
Countries citing papers authored by Hongzhou Lu
This map shows the geographic impact of Hongzhou Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hongzhou Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hongzhou Lu more than expected).
Fields of papers citing papers by Hongzhou Lu
This network shows the impact of papers produced by Hongzhou Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hongzhou Lu. The network helps show where Hongzhou Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Hongzhou Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 0 | |
| 2 | 2024 | 13 | |
| 3 | 2024 | 4 | |
| 4 | 2024 | 8 | |
| 5 | 2023 | 3 | |
| 6 | 2023 | 7 | |
| 7 | 2023 | 0 | |
| 8 | 2023 | 1 | |
| 9 | 2022 | 17 | |
| 10 | 2021 | 2 | |
| 11 | 2021 | 29 | |
| 12 | 2021 | 17 | |
| 13 | 2020 | 29 | |
| 14 | 2020 | 11 | |
| 15 | 2020 | 21 | |
| 16 | 2020 | 5 | |
| 17 | 2019 | 2 | |
| 18 | 2018 | 11 | |
| 19 | 2017 | 1 | |
| 20 | 2010 | 1 |
About Hongzhou Lu
Hongzhou Lu is a scholar working on Virology, Infectious Diseases, Emergency Medicine, Epidemiology and Biological Psychiatry, having authored 236 papers that have together received 4.6k indexed citations. Recurring topics across this work include HIV/AIDS Research and Interventions (51 papers), HIV Research and Treatment (43 papers), HIV/AIDS drug development and treatment (35 papers), COVID-19 Clinical Research Studies (29 papers), SARS-CoV-2 and COVID-19 Research (26 papers), Tuberculosis Research and Epidemiology (24 papers), Pneumocystis jirovecii pneumonia detection and treatment (22 papers) and Non-Invasive Vital Sign Monitoring (22 papers). The work is most often cited by research in Infectious Diseases (2.6k citations), Virology (508 citations), Modeling and Simulation (220 citations), Neurology (606 citations) and Biological Psychiatry (66 citations). Hongzhou Lu has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Jun Chen, Yinzhong Shen, Li Liu, Yun Ling, Tangkai Qi, Tongyu Zhu, Zhiping Qian, Yuyi Zhang, Shuibao Xu and Qingnian Xu. Their work appears in journals such as BioScience Trends, Emerging Microbes & Infections, IEEE Journal of Biomedical and Health Informatics, AIDS Care and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.